NEW ORLEANS -- Despite ongoing scrutiny about its safety, nexiguran ziclumeran (nex-z) still had promising effectiveness data to hold onto. In an update on nex-z's phase I study, the CRISPR-Cas9 gene ...
− Treatment with Vutrisiran Led to 37- 49% Lower Rates of Gastrointestinal Events, a Multisystem Manifestation of ATTR-CM, Across Multiple Treatment Groups, Compared to Placebo – − Additional Analyses ...
Changed in version 3.12: If the low bit of namei is set, then a NULL or self is pushed to the stack before the attribute or unbound method respectively. And this can ...
BridgeBio Pharma announced promising results from its Phase 3 trial of acoramidis for transthyretin amyloid cardiomyopathy (ATTR-CM), revealing that early and sustained increases in serum ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced moderated poster presentations of new data from the landmark ...
− Vutrisiran Treatment Led to Maintenance or Improvement in Functional Capacity, Health Status, and Quality of Life, Compared to Placebo – “The HELIOS-B study continues to deliver a robust data ...
The United States economy appears to be precariously perched on the brink of recession. The stock market’s recent plunge reflects heightened recession fears, further exacerbated by a bleak jobs report ...
These are specific bite-sized projects to learn an aspect of deep learning, starting from scratch. There is an associated video around 10 minutes long. I assume no background in ML but some ...
The motives that drove archaeologists of the past included a thirst for glory, a taste for treasure and a desire to enshrine a new political era with the legitimacy of the ancient past. Gradually, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback